Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The CAARE Study
NCT02332291Phase 4Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- Apr 2015
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of escitalopram in major depressive disorder (MDD), sponsored by Vanderbilt University Medical Center. Started Apr 2015; status: completed.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02332291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02332291.